Breakpoint Working Group News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Breakpoint working group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Breakpoint Working Group Today - Breaking & Trending Today

The Clinical & Laboratory Standards Institute announces clinical breakpoints for azithromycin for Shigella | NARMS


Shigellosis is a nationally notifiable disease caused by
Shigella bacteria. There are an estimated 450,000 cases of shigellosis in the United States each year. Some common symptoms of shigellosis are diarrhea (that is sometimes bloody), fever, stomach pain, and feeling the need to pass stool (poop) even when the bowels are empty. Most people recover from shigellosis without treatment. But some people need antibiotics to treat or prevent severe illness and to shorten the duration of symptoms.
Some types of
Shigella are antibiotic resistant, which means they developed the ability to defeat the antibiotics designed to kill or stop their growth, and the infection may not be cured by that antibiotic. Compared with ....

United States , California Department Of Public Health , University Of Virginia , International Centre For Diarrheal Disease Research , Breakpoint Working Group , Clinical Laboratory Standards Institute , California Department Of Health , Antibiotic Treatment , California Department , International Centre , Diarrheal Disease Research , Public Health , Laboratory Standards Institute , Antimicrobial Susceptibility Testing , Treating Shigella With Azithromycin , Zithromycin Breakpoints For Shigella , Clinical Laboratory Standards Institute , Ntibiotic Resistant Shigella , Reating Antibiotic Resistant Infections , Usceptibility To Azithromycin , Higella Treatment Decisions , Ational Antimicrobial Resistance Monitoring System Narms , ஒன்றுபட்டது மாநிலங்களில் , கலிஃபோர்னியா துறை ஆஃப் பொது ஆரோக்கியம் , பல்கலைக்கழகம் ஆஃப் வர்ஜீனியா , மருத்துவ ஆய்வகம் தரநிலைகள் நிறுவனம் ,